Breaking News

AGC Biologics Forms Cell and Gene Technologies Division

The new division offers focused technical innovation, product platform design, scalable manufacturing, and a friendly customer experience for the Advanced Therapy market.

Author Image

By: Charlie Sternberg

Associate Editor

AGC Biologics, a CDMO, has formed a new Cell and Gene Technologies Division designed to focus and elevate existing AGC Biologics capabilities. The new AGC Biologics Cell and Gene Technologies Division offers support and scientific ability, backed by a global development and manufacturing network in three regions (Milan, Italy; Longmont, CO, USA; Yokohama, Japan). Furthermore, AGC Biologics’ proprietary cell therapy and viral vector platforms, including ProntoLVV and BravoAAV, offer deve...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters